Prism Medico and Pharmacy Ltd

Prism Medico & Pharmacy Q2 FY2025 Results: Revenue at ₹50.23 Lakhs 📊

- Board approved Unaudited Standalone Financial Results for Q2 & H1 ended 30th Sept 2025

- Revenue from operations: ₹50.23 lakhs (quarter)

- Total income from operations: ₹51.90 lakhs (quarter)

- Total expenses: ₹60.38 lakhs (quarter)

- Loss before tax: ₹8.48 lakhs (quarter)

- Paid-up equity share capital: ₹606.34 lakhs

- Financials prepared under Indian Accounting Standards (Ind AS)

- Single business segment (no segment reporting required per IND AS 108)